BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16305638)

  • 1. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
    Szodoray P; Jonsson R
    Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
    Szodoray P; Alex P; Jonsson MV; Knowlton N; Dozmorov I; Nakken B; Delaleu N; Jonsson R; Centola M
    Clin Immunol; 2005 Nov; 117(2):168-76. PubMed ID: 16126006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
    d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome.
    Szodoray P; Jellestad S; Teague MO; Jonsson R
    Lab Invest; 2003 Mar; 83(3):357-65. PubMed ID: 12649336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BAFF/APRIL system: life beyond B lymphocytes.
    Ng LG; Mackay CR; Mackay F
    Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
    Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
    J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.
    Mackay F; Tangye SG
    Curr Opin Pharmacol; 2004 Aug; 4(4):347-54. PubMed ID: 15251127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
    Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
    Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome.
    Delaleu N; Jonsson R; Koller MM
    Eur J Oral Sci; 2005 Apr; 113(2):101-13. PubMed ID: 15819815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.
    Mackay F; Groom JR; Tangye SG
    Curr Opin Rheumatol; 2007 Sep; 19(5):406-13. PubMed ID: 17762603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF overexpression is associated with autoantibody production in autoimmune diseases.
    Pers JO; Daridon C; Devauchelle V; Jousse S; Saraux A; Jamin C; Youinou P
    Ann N Y Acad Sci; 2005 Jun; 1050():34-9. PubMed ID: 16014518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF.
    Szodoray P; Jellestad S; Alex P; Zhou T; Wilson PC; Centola M; Brun JG; Jonsson R
    J Clin Immunol; 2004 Nov; 24(6):600-11. PubMed ID: 15622444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
    Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
    Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
    Nakamura H; Kawakami A; Eguchi K
    Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.